[Federal Register Volume 62, Number 171 (Thursday, September 4, 1997)] [Notices] [Pages 46742-46743] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-23577] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Clinical Laboratory Improvement Advisory Committee (CLIAC) Meeting FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: FR Doc. 97-21100 Filed 8/8/97. Published 8/11/97 (Volume 62, Number 154, Pages 42997- 42998). PREVIOUSLY ANNOUNCED TIMES AND DATES OF THE MEETING: 8:30 a.m.-4:30 p.m., September 11, 1997, 8:30 a.m.-4:30 p.m., September 12, 1997. CHANGES TO THE NOTICE: Addition to the announced agenda: For the afternoon of September 11, discussion of the new FDA category ``home use with a prescription'' and considerations for waiver of such laboratory tests under the Clinical Laboratory Improvement Amendments regulations. CONTACT PERSON FOR MORE INFORMATION: John Ridderhof, Dr. P.H., Division of Laboratory Systems, Public Health Practice Program Office, CDC, 4770 Buford Highway, NE, MS G25, Atlanta, Georgia 30341-3724, telephone 770/ 488-7660. [[Page 46743]] Dated: August 29, 1997. Carolyn J. Russell, Director, Management Analysis and Services Office Centers for Disease Control and Prevention (CDC). [FR Doc. 97-23577 Filed 9-2-97; 1:35 pm] BILLING CODE 4163-18-P